Blood Pressure-Lowering Peptides Hidden in Your Food

This is a narrative review surveying published literature on food-derived antihypertensive peptides. It covers peptide sources (dairy, animal, plant, and other food proteins), mechanisms of action (renin inhibition, ACE inhibition, angiotensin II receptor blocking, nitric oxide enhancement), and applications for cardiovascular disease management.

Hypertension affects over a billion people worldwide and is the leading modifiable risk factor for cardiovascular disease. While pharmaceutical ACE inhibitors are highly effective, food-derived peptides offer a potential complementary approach with fewer side effects. Understanding which foods naturally contain blood pressure-lowering peptides could inform dietary recommendations and functional food development for people with mild hypertension or those seeking to prevent it.

Food-derived bioactive peptides represent a growing area at the intersection of nutrition science and pharmacology. Several peptide-containing products — particularly fermented milk products like lactotripeptides (IPP and VPP) — have been commercialized as functional foods for blood pressure management in Japan and Europe. As regulatory frameworks for health claims evolve, food-derived peptides may increasingly bridge the gap between dietary intervention and pharmaceutical treatment.

As a narrative review, it synthesizes existing literature without conducting meta-analysis or quantifying effect sizes. Most food-derived peptide research involves in vitro ACE inhibition assays or small clinical studies — large-scale human trials are limited. The blood pressure-lowering effects of food peptides are generally modest compared to pharmaceutical ACE inhibitors.